Fuzionaire Theranostics Revenue

Pharmaceutical Manufacturing • The Woodlands, Texas, United States • 1-10 Employees

Fuzionaire Theranostics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$1,100,000
Total funding	No funding

Key Contact at Fuzionaire Theranostics

Thomas Singleton

Vice President, Chemistry

Company overview

Headquarters	2002 Timberloch Pl, Suite 200, The Woodlands, Texas 77380, US
Website	fuzionairetx.com
NAICS	3254
Founded	2018
Employees	1-10
Socials

About Fuzionaire Theranostics

Fuzionaire Theranostics is a radiopharmaceutical company on a mission to make better and more accessible theranostic treatments for people with cancer. With origins in Nobel laureate Robert Grubbs' lab at Caltech, the company's patented HetSiFA® platform enables rapid development of radioligand therapies and companion PET diagnostics, and offers manufacturing advantages in a clinical setting. The company’s pipeline addresses pressing clinical needs for several types of cancer, beginning with cancers in which gastrin-releasing peptide receptor (GRPR) is expressed, including metastatic prostate cancer.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Vice President

Employees by Department

Fuzionaire Theranostics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Fuzionaire Theranostics has never raised funding before.

Fuzionaire Theranostics Tech Stack

Discover the technologies and tools that power Fuzionaire Theranostics's digital infrastructure, from frameworks to analytics platforms.

Google Tag Manager

Tag managers

GoDaddy

Hosting

HSTS

Security

Open Graph

Miscellaneous

Vimeo

Video players

core-js

JavaScript libraries

PWA

Miscellaneous

Google Analytics

Analytics

Netlify

CDN

Frequently asked questions

Fuzionaire Theranostics is located in The Woodlands, Texas, US.

Fuzionaire Theranostics generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.

Fuzionaire Theranostics has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Fuzionaire Theranostics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Fuzionaire Theranostics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Fuzionaire Theranostics

Thomas Singleton

Vice President, Chemistry

4.8

40,000 users